The Hub-Lite™ model offers an efficient approach to drugs whose cost or pattern of treatment don’t justify the expense of full-fledged patient services.
April 2016: The Goldilocks Hub
April 1st 2016The gap is continually growing between high-priced specialty therapies and retail pharmaceuticals. At CBI’s 6th Annual Hub and SPP Model Optimization Conference in Philadelphia this February, Triplefin’s Myra Reinhardt, Vice President of Product Strategy, discussed how Hub services can be tailored to fit “just right” for brands with price points and patient service requirements that are neither too big nor too small.